Statistician - PhD candidate in Pharmacoepidemiology
EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
Paris, France
After working for almost 4 years in the Health Products Department of the French National Health Insurance, I joined EPI-PHARE, a scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, in February 2020 as a statistician and pharmaco-epidemiologist.
Since then, I've had the opportunity to work on several pharmaco-epidemiological studies on COVID-19 (risk factors for severe covid-19, vaccine effectiveness, etc...).
Since November 2022, I'm a PhD candidate in pharmaco-epidemiology.
Disclosure information not submitted.
Influence of mRNA Covid-19 Vaccine Dosing Interval on the Risk of Myocarditis
Monday, August 26, 2024
1:45 PM – 2:00 PM CEST